The business intelligence report titled ‘Asia Pacific Orthopedic Devices Market Forecast 2027 By Product, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, states that Asia Pacific orthopedic devices market is slated to witness a colossal growth and amass a valuation of USD 13.4 billion by the end of 2027. 

Growing geriatric population, increasing prevalence pf bone related diseases or disorders as well as significant technological advancements in the field are the factors augmenting Asia Pacific orthopedic devices market size.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4384875/  

Certifiable sources claim that a sizable part of the population in China and Japan is comprised of citizens who have crossed 65 years of age, making them susceptible to orthopedic diseases or fractures, thereby fostering market remuneration.

Despite the positive outlook, the expensive nature of orthopedic devices, post-surgery complications, stringent FDA regulations, and biocompatibility issues may hinder the growth trajectory of the marketplace during the analysis timeframe.

The Asia Pacific orthopedic devices industry landscape is segregated in terms of product type and regional terrain.

Based on product type, joint reconstruction devices segment held an industry share of 42% in 2020. This can be attributed to the increasing demand for high tech implants that fit perfectly and not cause any post operative complications. Furthermore, the advent of minimally invasive joint reconstruction procedures that drastically reduce the chances of scarring, hospital stay period, and quickens recovery time of the patients is instrumental in widening remuneration scope for the market in the forthcoming
years.

Meanwhile, the spinal devices segment captured nearly 20% market share in 2020, creditable to the penetration of minimally invasive surgical procedures, alongside extensive device utilization in strengthening the spine and in treating fractures, spondylolisthesis, scoliosis and many other deformities that require spinal fusion.

Geographically, Japan orthopedic devices industry size is anticipated to surpass a valuation of USD 2.58 billion by the end of 2027, owing to significant technological advancements and rising geriatric population in the country.

The competitive framework of the industry is influenced by major players such as Zimmer Biomet, Waldemar Link GmbH & Co. KG., Stryker Corporation, Smith & Nephew plc, NuVasive Inc., Microport Scientific Corporation, Medtronic plc, Medacta International SA, Integra LifeSciences, Globus Medical Inc., DJO Global Inc., DePuy Synthes Companies, ConforMis Inc., B. Braun Melsungen AG., Arthrex, Alphatec Spine Inc., and aap Implantate AG.